Format

Send to

Choose Destination
Haematologica. 2019 Aug 29. pii: haematol.2019.223073. doi: 10.3324/haematol.2019.223073. [Epub ahead of print]

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematological malignancies and after hematopoietic stem cell transplantation.

Author information

1
Division of Infection & Immunity, University College London, London, UK; k.n.ward@ucl.ac.uk.
2
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
3
Charles University & Motol University Hospital Prague, Czech Republic.
4
Department of Haematology, Hospital de la Princesa, Madrid, Spain.
5
SIMT, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy.
6
Medizinische Clinic und Pliklinik IIJulius Maximilians Universitaet, Würzburg, Germany.
7
Instituto de Investigacion INCLIVA, University of Valencia, Spain.
8
Henri Mondor & Assistance Publique-Hospitaux de Paris, Universite Paris-Est Creteil, France.
9
Karolinska University Hospital, Karolinska Instutet, Stockholm, Sweden.

Abstract

HHV-6B encephalitis is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplant. Guidelines for the management of HHV-6 infections in patients with hematological malignancies or post-transplant were prepared a decade ago but there have been no other guidelines since then despite significant advances in the understanding of HHV-6 encephalitis, its therapy, and other aspects of HHV-6 disease in this patient population. Revised guidelines prepared at the 2017 European Conference on Infections in Leukaemia covering diagnosis, preventative strategies and management of HHV-6 disease are now presented.

KEYWORDS:

CIHHV-6; Encephalitis; HHV-6; Hematopoietic Stem Cell; Infectious Disorders

PMID:
31467131
DOI:
10.3324/haematol.2019.223073
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center